| Impact of surfactants on the crystallization of aqueous suspensions of celecoxib amorphous solid dispersion spray dried particles J Chen, JD Ormes, JD Higgins, LS Taylor Molecular pharmaceutics 12 (2), 533-541, 2015 | 155 | 2015 |
| Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder SD Edmondson, C Zhu, NF Kar, J Di Salvo, H Nagabukuro, ... Journal of Medicinal Chemistry 59 (2), 609-623, 2016 | 114 | 2016 |
| Bile salts as crystallization inhibitors of supersaturated solutions of poorly water-soluble compounds J Chen, LI Mosquera-Giraldo, JD Ormes, JD Higgins, LS Taylor Crystal Growth & Design 15 (6), 2593-2597, 2015 | 94 | 2015 |
| Insights into nano-and micron-scale phase separation in amorphous solid dispersions using fluorescence-based techniques in combination with solid state nuclear magnetic … HS Purohit, JD Ormes, S Saboo, Y Su, MS Lamm, AKP Mann, LS Taylor Pharmaceutical research 34, 1364-1377, 2017 | 70 | 2017 |
| Drug release and nanodroplet formation from amorphous solid dispersions: insight into the roles of drug physicochemical properties and polymer selection R Yang, AKP Mann, T Van Duong, JD Ormes, GA Okoh, A Hermans, ... Molecular Pharmaceutics 18 (5), 2066-2081, 2021 | 62 | 2021 |
| A comparison of the crystallization inhibition properties of bile salts N Li, LI Mosquera-Giraldo, CH Borca, JD Ormes, M Lowinger, JD Higgins, ... Crystal Growth & Design 16 (12), 7286-7300, 2016 | 61 | 2016 |
| Maintaining supersaturation of active pharmaceutical ingredient solutions with biologically relevant bile salts J Lu, JD Ormes, M Lowinger, AKP Mann, W Xu, JD Litster, LS Taylor Crystal Growth & Design 17 (5), 2782-2791, 2017 | 42 | 2017 |
| Impact of endogenous bile salts on the thermodynamics of supersaturated active pharmaceutical ingredient solutions J Lu, JD Ormes, M Lowinger, W Xu, A Mitra, AKP Mann, JD Litster, ... Crystal Growth & Design 17 (3), 1264-1275, 2017 | 39 | 2017 |
| Impact of bile salts on solution crystal growth rate and residual supersaturation of an active pharmaceutical ingredient J Lu, JD Ormes, M Lowinger, AKP Mann, W Xu, S Patel, JD Litster, ... Crystal Growth & Design 17 (6), 3528-3537, 2017 | 34 | 2017 |
| Design of experiments utilization to map the processing capabilities of a micro-spray dryer: particle design and throughput optimization in support of drug discovery JD Ormes, D Zhang, AM Chen, S Hou, D Krueger, T Nelson, A Templeton Pharmaceutical development and technology 18 (1), 121-129, 2013 | 33 | 2013 |
| In situ analytical characterization and chemical imaging of tablet coatings using laser induced breakdown spectroscopy (LIBS) L Zou, B Kassim, JP Smith, JD Ormes, Y Liu, Q Tu, X Bu Analyst 143 (20), 5000-5007, 2018 | 19 | 2018 |
| The renal outer medullary potassium channel inhibitor, MK-7145, lowers blood pressure, and manifests features of Bartter’s syndrome Type II phenotype C Hampton, X Zhou, BT Priest, LY Pai, JP Felix, B Thomas-Fowlkes, J Liu, ... Journal of Pharmacology and Experimental Therapeutics 359 (1), 194-206, 2016 | 19 | 2016 |
| Leaching of lopinavir amorphous solid dispersions in acidic media N Li, JD Ormes, LS Taylor Pharmaceutical research 33, 1723-1735, 2016 | 18 | 2016 |
| Effect of drug incorporation and polymer properties on the characteristics of electrospun nanofibers for drug delivery MB Gelb, A Punia, S Sellers, P Kadakia, JD Ormes, NN Khawaja, J Wylie, ... Journal of Drug Delivery Science and Technology 68, 103112, 2022 | 17 | 2022 |
| Compositional effect of complex biorelevant media on the crystallization kinetics of an active pharmaceutical ingredient J Lu, JD Ormes, M Lowinger, AKP Mann, W Xu, S Patel, JD Litster, ... CrystEngComm 19 (32), 4797-4806, 2017 | 17 | 2017 |
| High bulk-density amorphous dispersions to enable direct compression of reduced tablet size amorphous dosage units DS Frank, H Nie, A Chandra, A Coelho, C Dalton, H Dvorak, A Elkhabaz, ... Journal of Pharmaceutical Sciences 112 (8), 2037-2045, 2023 | 11 | 2023 |
| Direct visualization of drug release in injectable implant by laser induced breakdown spectroscopy (LIBS) L Zou, MJ Stenslik, MB Giles, JD Ormes, M Marsales, C Santos, B Kassim, ... Journal of Analytical Atomic Spectrometry 34 (7), 1351-1354, 2019 | 10 | 2019 |
| How broadly can poly (urethane)-based implants be applied to drugs of varied properties? MB Lowinger, JD Ormes, Y Su, JH Small, RO Williams III, F Zhang International Journal of Pharmaceutics 568, 118550, 2019 | 9 | 2019 |
| Solubility and dissolution considerations for amorphous solid dispersions GA Ilevbare, W Xu, CT John, JD Ormes, JL Kuiper, AC Templeton, A Bak Pharmaceutical Amorphous Solid Dispersions, 218, 2015 | 9 | 2015 |
| Improved stability of proline-derived direct thrombin inhibitors through hydroxyl to heterocycle replacement HR Chobanian, B Pio, Y Guo, H Shen, MA Huffman, M Madeira, ... ACS Medicinal Chemistry Letters 6 (5), 553-557, 2015 | 6 | 2015 |
Lynne TaylorProfessor of Industrial and Physical Pharmacy, Purdue UniversityVerified email at purdue.edu
